--- title: "US IPO Weekly Recap: Seven IPOs make it one of the busiest weeks in four years" description: "Seven IPOs and six SPACs were priced this week, marking one of the busiest weeks in four years. Notable IPOs include Veradermics, which raised $256 million, and Forgent Power Solutions, which raised $" type: "news" locale: "en" url: "https://longbridge.com/en/news/275186396.md" published_at: "2026-02-07T01:00:49.000Z" --- # US IPO Weekly Recap: Seven IPOs make it one of the busiest weeks in four years > Seven IPOs and six SPACs were priced this week, marking one of the busiest weeks in four years. Notable IPOs include Veradermics, which raised $256 million, and Forgent Power Solutions, which raised $1.5 billion. Other companies like Bob’s Discount Furniture and Once Upon a Farm also made their market debuts. SPACs raised a total of $1.1 billion, with several others filing for future offerings. This surge in IPO activity reflects a growing interest in the market, particularly in biotech and technology sectors. Seven IPOs and six SPACs priced this week. Five IPOs and five SPACs submitted filings. Hair loss biotech **Veradermics** (MANE), priced its upsized IPO above the range to raise $256 million at a $612 million market cap. The dermatologist-founded, late clinical-stage biopharmaceutical company is developing an oral, non-hormonal extended-release formulation of minoxidil for male and female pattern hair loss. Veradermics has fully enrolled its Phase 2/3 trial in men and has initiated two additional Phase 3 registration-directed trials in male and female patients to support an NDA, targeting a large, underserved population. Veradermics finished the week up 126%. Electrical equipment maker **Forgent Power Solutions** (FPS) priced its IPO at the midpoint to raise $1.5 billion at an $8.2 billion market cap. At pricing, Forgent is coming public at 24x 2026 EBITDA, two turns above the median of a peer group of primarily larger, more well-established electrical distribution equipment providers. The designer and manufacturer of electrical distribution equipment serves data centers, power grids, and industrial facilities with a broad suite of products, including transformers and switchgear. Forgent finished the week up 25%. Furniture retailer **Bob’s Discount Furniture** (BOBS) priced its IPO at the low end of the range to raise $331 million at a $2.3 billion market cap. Bob's is coming to market at roughly 8x 2027 EBITDA, a discount to the multiples of Arhaus (11x) and RH (10x) as well as a broader group of furniture and home goods retailers. Bob’s finished the week down 3%. Jennifer Garner’s baby food brand **Once Upon a Farm** (OFRM) priced its IPO at the midpoint to raise $198 million at an $811 million market cap. While the company offers well-above average growth, it is amongst the smallest of its peers and remains unprofitable, unlike nearly all of its peers, though its margins are improving rapidly. Once Upon a Farm finished out the week up 17%. Chronic eye condition biotech **SpyGlass Pharma** (SGP) priced its IPO at the midpoint to raise $150 million at a $549 million market cap. SpyGlass is a late-stage biopharmaceutical company focused on chronic eye conditions by developing durable drug delivery solutions that provide long-term disease control and vision preservation. It finished the week up 65%. Belgian fibrotic disease biotech **AgomAb Therapeutics** (AGMB) priced its US IPO at the midpoint to raise $200 million at an $875 million market cap. AgomAb is advancing novel organ-restricted ALK5 inhibitors, targeting a well-established pathway for fibrosis while avoiding systemic toxicities. Both Crohn’s disease and IPF therapies are multi-billion-dollar markets, despite the limited efficacy of existing drugs, underscoring the blockbuster potential of AgomAb’s pipeline. AgomAb finished the week down 8%. **Eikon Therapeutics** (EIKN) priced its upsized IPO at the top of the range to raise $381 million at a $1.0 billion market cap. Led by former Merck execs, Eikon raised over $1.1 billion as a private company, most recently raising $351 million in February 2025 at an as-converted price of $43.55 per share. According to media reports, Merck intended to invest $30 million on the IPO. It is important to note that the biotech has a high cash burn rate, and its original discovery platform, built around super-resolution microscopy, is relatively unproven. Eikon's appeal to investors primarily rests on CEO Roger Perlmutter and his team's earlier successes at Merck. Eikon finished the week down 20%. Six SPACs also priced this week. **Hennessy Capital VIII** (HCICU) raised $210 million in an upsized IPO to target industrial innovation and energy. **Cantor Equity Partners VI** (CEPS), the fifteenth blank check company formed by Cantor Fitzgerald, raised $100 million. **Colombier Acquisition III** (CLBR.U), led by Omeed Malik and 1789 Capital Executives, raised $260 million. **SPACSphere Acquisition** (SSACU), led by veterans Bala Padmakumar and Soumen Das, raised $150 million. **Iris Acquisition II** (IRABU), led by executives from Arrow Capital, raised $150 million. **Cambridge Acquisition** (CAQUU) raised $200 million to target the tech sector. Five SPACs also submitted initial filings. **MOZAYYX Acquisition** (MZYX.U) filed to raise $250 million, targeting tech, fintech, and high growth areas. **Kensington Capital VI** (KCAC.U) filed to raise $200 million, targeting the auto industry. **Metals Acquisition II** (MTAL.U) also filed to raise $200 million, targeting mining. **Pono Capital Four** (PONOU) filed to raise $150 million, targeting disruptive technology. **Apeiron Acquisition I** (APNU) filed to raise $70 million, targeting international operations. ### Related Stocks - [MANE.US - VeraDermics](https://longbridge.com/en/quote/MANE.US.md) - [FPS.US - Forgent Power Solutions](https://longbridge.com/en/quote/FPS.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Major Insider Move Signals Growing Confidence in Veradermics | Insider activity at Veradermics, Incorporated (MANE) on February 9, 2026, shows growing confidence as Director Suvretta | [Link](https://longbridge.com/en/news/275397754.md) | | Forgent Power Solutions Completes IPO and NYSE Listing | Forgent Power Solutions, Inc. has successfully completed its IPO, pricing 56 million Class A shares at $27 each, with tr | [Link](https://longbridge.com/en/news/275459953.md) | | TRG Latin America Acquisitions Closes $200 Million IPO | TRG Latin America Acquisitions Closes $200 Million IPO | [Link](https://longbridge.com/en/news/277250155.md) | | It’s a wrap: Sweetgreen goes handheld ahead of earnings | Sweetgreen is rolling out wraps in select markets as same-store sales are expected to fall and shares remain far below t | [Link](https://longbridge.com/en/news/277115930.md) | | Fortress Value Acquisition Corp. V Closes $250 Million IPO | Fortress Value Acquisition Corp. V Closes $250 Million IPO | [Link](https://longbridge.com/en/news/277243217.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.